| (SEK) | Dec 2021 | Y/Y change |
|---|---|---|
| Revenue | 4.43M | — |
| Operating expense | — | — |
| Net income | -14.32M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, EXPRS2.ST returned -94.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -91.6% |
| 1 year | -94.2% |
| 5 years | -99.9% |
| 10 years | -99.3% |
| All-time high | kr 1,568.87 (Jul 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in EXPRS2.ST would be worth today ›No. ExpreS2ion Biotech Holding AB (publ) has not paid a dividend in the past 12 months.
ExpreS2ion Biotech Holding AB (publ) is part of the Healthcare sector.
ExpreS2ion Biotech Holding AB (publ) has a market cap of 13.24M SEK, based on the latest quote.
ExpreS2ion Biotech Holding AB (publ) is scheduled to report earnings on Nov 12, 2026.
